Research Paper Volume 13, Issue 23 pp 25453—25465

A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients

class="figure-viewer-img"

Figure 5. Correlations of the risk model (RiskScore) based on nine autophagy-related lncRNA pairs with tumor-infiltrating immune cell landscape.